<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-QSB
[X] Quarterly Report Under Section 13 or 15(d) of The Securities Exchange
Act of 1934
For the quarterly period ended September 30, 1998
[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
For the transition period from __________________ to ______________________.
Commission file number 333-19285
MYO DIAGNOSTICS, INC.
- -------------------------------------------------------------------------------
(Exact Name of Small Business Issuer as Specified in its Charter)
California
- -------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation or Organization)
95-4089525
- -------------------------------------------------------------------------------
(I.R.S. Employer Identification No.)
3710 South Robertson Boulevard
Culver City, California 90232
- -------------------------------------------------------------------------------
(Address of Principal Executive Offices)
310-559-5500
- -------------------------------------------------------------------------------
(Issuer's Telephone Number, Including Area Code)
Check whether the issuer: (1) filed all reports required to be filed by
Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such
shorter period that the registrant was required to file such reports), and (2)
has been subject to such filing requirements for past 90 days.
Yes [ ] No [X]
State the number of shares outstanding of each of the issuer's classes of
common equity, as of the latest practicable date: Common Stock, no par value,
8,616,370 shares issued and outstanding as of October 1, 1998.
Transitional Small Business Disclosure Format (check one):
Yes [ ] No [X]
<PAGE> 2
MYO DIAGNOSTICS, INC.
INDEX TO FORM 10-QSB
PART I FINANCIAL INFORMATION Page
Item 1. Financial Statements:
Balance Sheet (unaudited) as of September 30, 1998 3
Statements of Operations (unaudited) for the
Nine months Ended September 30, 1998 and 1997 4
Statements of Cash Flows (unaudited) for the
Nine months Ended September 30, 1998 and 1997 5
Notes to Financial Statements 6
Item 2. Management's Discussion and Analysis of Financial
Condition and Results of Operations 7
PART II OTHER INFORMATION
Item 1. Legal Proceedings 9
Item 2. Changes in Securities 9
Item 3. Defaults Upon Senior Securities 9
Item 4. Submission of Matters to a Vote of Security Holders 9
Item 5. Other Information 9
Item 6. Exhibits and Reports on Form 8-K. 9
<PAGE> 3
PART I
FINANCIAL INFORMATION
Item 1. Financial Statements
MYO DIAGNOSTICS, INC.
(A DEVELOPMENT STAGE COMPANY)
BALANCE SHEET
(Unaudited)
Sep 30, 1998
Current Assets ____________
Cash $ -
Accounts receivable -
Prepaid expenses and other current assets 6,039
____________
Total current assets 6,039
Fixed assets 154,977
Other assets 32,204
____________
Total assets $ 193,220
Current Liabilities
Accounts payable and accrued expenses 475,055
Notes payable to bank 270,000
Current portion of leases payable 9,813
____________
Total current liabilities 754,868
Non Current Liabilities
Convertible debenture loans 167,000
Loans from shareholders - 44,000
Capital leases payable 64,752
Notes payable 25,000
____________
Total liabilities 1,055,620
Shareholders' Equity (Deficit)
Preferred stock, no par value
10,000,000 shares authorized
No shares issued and outstanding -
Common stock, no par value
50,000,000 shares authorized
8,616,370 and 8,323,037 issued and
outstanding 5,769,956
Paid in capital 145,000
Deficit accumulated during development stage (6,777,356)
____________
Total shareholders' deficit (862,400)
____________
Total liabilities and shareholders' deficit $ 193,220
The accompanying notes are an integral part of these financial statements.
<PAGE> 4
MYO DIAGNOSTICS, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF OPERATIONS
(Unaudited)
Three Months Nine months
ended Sept 30, ended Sept 30,
1998 1997 1998 1997
_________ _________ _________ _________
Revenues $ - $ 4,197 $ - $ 9,771
Operating Expenses:
Research and Development 53,193 96,041 276,887 278,455
Technical Services 28,229 47,893 89,493 170,637
Sales and Marketing 16,038 26,599 88,187 66,145
General and Administrative 175,826 238,365 598,098 613,771
_________ _________ _________ _________
Total Operating Expenses 273,286 408,898 1,052,665 1,129,008
_________ _________ _________ _________
Loss from Operations (273,286) (404,701) (1,052,665) (1,119,237)
Other Income (Expenses)
Interest Expense (6,746) (11,955) (23,719) (37,043)
Miscellaneous - - - -
Interest Income - 6,155 233 38,180
__________ _________ ________ _________
Total Other Income (Expenses) (6,746) (5,800) (23,496) 1,137
Loss before provision for
income taxes (280,032) (410,501) (1,076,161) (1,118,100)
Provision for income taxes (279) - 1,264 800
__________ __________ _________ _________
Net loss $ (279,753) $(410,501) $(1,077,425) $(1,118,900)
__________ __________ _________ _________
Net loss per share $ (0.03) $ ( 0.05) $ (0.13) $ (0.14)
Weighted average number of 8,469,704 8,223,037 8,469,704 8,034,539
shares outstanding
The accompanying notes are an integral part of these financial statements.
<PAGE> 5
MYO DIAGNOSTICS, INC.
(A DEVELOPMENT STAGE COMPANY)
STATEMENTS OF CASH FLOWS
(Unaudited)
Nine Months ended Sept 30,
1998 1997
____________ ____________
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss $ (1,077,425) $ (1,118,900)
Adjustments to reconcile net loss to net cash
used in operating activities:
Depreciation and amortization 47,136 39,929
Changes in operating assets and liabilities:
(Increase) decrease in assets:
Accounts receivable 67,500 (7,662)
Prepaid expenses 6,912 (10,380)
Other assets 825 420
Increase (decrease) in liabilities:
Accounts payable and accrued
expenses 245,632 (3,149)
____________ ____________
Net Cash Used in Operating
Activities (709,420) (1,099,742)
____________ ____________
CASH FLOWS FROM INVESTING ACTIVITIES:
Equipment purchases (34,240) (14,521)
____________ ____________
Net Cash Used in Investing Activities (34,240) (14,521)
____________ ____________
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from bank overdraft 27,420 (130,000)
Proceeds from notes payable 69,000 -
Convertible Debenture 167,000 -
Net proceeds from issuance of common stock 330,817 1,200,000
(Repayments) borrowings of obligations under
capital lease (1,085) (19,266)
____________ ____________
Net Cash Provided by Financing Activities 593,152 1,050,734
____________ ____________
Net (Decrease) in Cash (150,508) (63,529)
CASH -- Beginning of Period 150,508 606,144
____________ ____________
CASH -- End of Period $ - $ 542,615
<PAGE> 6
MYO DIAGNOSTICS, INC.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO FINANCIAL STATEMENTS
(Unaudited)
1. Basis of Presentation and Significant Accounting Policies
The financial statements included herein have been prepared by Myo
Diagnostics, Inc. (the "Company"), without audit, according to the rules and
regulations of the Securities and Exchange Commission. Certain information and
footnote disclosures normally included in financial statements prepared in
accordance with generally accepted accounting principles have been condensed or
omitted pursuant to such rules and regulations, although the Company believes
the disclosures that are made are adequate to make the information presented not
misleading. Further, the financial statements reflect, in the opinion of
management, all adjustments necessary to state fairly the financial position and
results of operations as of and for the periods indicated. These financial
statements should be read in conjunction with the Company's December 31, 1997
audited financial statements and notes thereto.
The financial statements have been prepared on the basis of the
continuation of the Company as a going concern. However, during the nine months
ended September 30, 1998, the Company incurred a net loss of $1,077,425. The
Company is also in the development stage at September 30, 1998, and recovery of
the Company's assets is dependent upon future events, the outcome of which is
indeterminable. Successful completion of the Company's development program and
its transition to the attainment of profitable operations is dependent upon
obtaining adequate financing to fulfill its development activities and achieving
a level of sales adequate to support the Company's cost structure. In view of
these matters, realization of a major portion of the assets in the accompanying
balance sheet is dependent upon the Company's ability to meet its financing
requirements and the success of its plans to sell its products. Further, the
results of operations for the nine months ended September 30, 1998 are not
necessarily indicative of results to be expected for the full fiscal year ending
December 31, 1998.
The Company is a development stage company as defined in Statement of
Financial Accounting Standards ("SFAS") No. 7, "Accounting and Reporting by
Development Stage Enterprises." The Company is devoting substantially all of
its present efforts to establish a new business and its planned principal
operations have not yet commenced. All losses accumulated since inception have
been considered as part of the Company's development stage activities.
Item 2. Management's Discussion and Analysis of Financial Condition and
Results of Operations
The Company is a development stage company that has yet to realize any
material revenues. The Company is ready to bring its product to market, but
needs additional funding to implement its marketing plan.
Forward Looking Statements
The Company may from time to time make "forward-looking statements" within
the meaning of Section 27A of the Securities Act of 1933, as amended, and
Section 21E of the Securities Exchange Act of 1934, as amended. When used in
this discussion, the words "estimate", "project", "anticipate" and similar
expressions are subject to certain risks and uncertainties, such as changes in
general economic conditions, competition, changes in federal regulations, as
well as uncertainties relating to raising additional financing and acceptance of
the Company's product and services in the marketplace, including those discussed
below that could cause actual results to differ materially from those projected.
Readers are cautioned not to place undue reliance on these forward-looking
statements, which speak only as to the date hereof. The Company undertakes no
obligation to publicly release the results of any revisions to those
forward-looking statements which may be made to reflect events or circumstances
after the date hereof or to reflect the occurrence of unanticipated events.
<PAGE> 7
Results of Operations
Nine Months Ended September 30, 1998 as Compared to Nine Months Ended
September 30, 1997. The Company incurred net losses of $1,077,425 for the
nine months ended September 30, 1998 and $1,118,900 for the nine months ended
September 30, 1997.
The Company's operating expenses decreased to $1,052,665 during the nine
months ended September 30, 1998 from $1,129,008 during the nine months ended
September 30, 1997. During the nine months ended September 30, 1998 compared
to the nine months ended June 30, 1997, research and development expenses
decreased $1,568. Technical service expenses decreased $81,114 due to limited
financial resources. Sales and marketing expenses for the nine months ended
September 30, 1998 increased $22,042 compared to the nine months ended
September 30, 1997 due to a slight increase in marketing efforts. During the
nine months ended September 30, 1998 compared to the nine months ended September
30, 1997, general and administrative expenses increased to $598,098 from
$613,771 respectively.
Financial Condition
The Company has funded its operating expenses principally through equity
and debt financings, as the Company has had no material cash flows from
operations. During the nine months ended September 30, 1998, the Company funded
its operations principally from bank overdraft facilities, from net proceeds of
$167,000 from the issuance of Convertible Notes and from net proceeds of
$200,000 from a private placement of Common Stock of the Company. See Part II,
Item 2 of this Form 10QSB.
The Company currently has four revolving lines of credit from a commercial
bank pursuant to which the Company may from time to time borrow up to an
aggregate of $270,000 at interest rates equal to the bank's prime rate of
interest plus .75% to 1.50%. These lines, which were fully utilized at
September 30, 1998, matured at various times through June 10, 1998. The Company
is currently negotiating with the bank for an extension of these lines.
The Company presently has funds to continue operations at its present level
only through December of 1998. The Company expects very little or no revenues
during this period, and is attempting to raise additional capital. If the
Company does not obtain additional capital by the end of December 1998, it will
be forced to severely curtail operations and, if additional capital is not
obtained shortly thereafter, the Company may be forced to cease operations.
<PAGE> 8
PART II
OTHER INFORMATION
Item 1. Legal Proceedings
N/A
Item 2. Changes in Securities
In July 1998, the Company issued to 31 shareholders of the Company, all of
whom are Canadian residents, 10% Convertible Notes due August 13, 2000 (the
"Notes") in aggregate principal amount of $167,000 for a purchase of $167,000.
The Notes are convertible into Common Stock at any time prior to maturity at
$1.00 per share. No underwriting discounts or brokerage commissions were paid
in connection with these issuances. The issuance of these securities was exempt
from registration under the Securities Act of 1933, as amended, pursuant to
Section 4(2) of the Securities Act, as a transaction not involving a public
offering, and pursuant to Regulation S as an off-shore transaction with an
investor which is not a U.S. Person.
In August 1998 the Company entered into an agreement with St. James
Securities Inc., a registered broker-dealer under Canadian law in Toronto,
Canada, pursuant to which St. James Securities agreed to purchase from the
Company as principal 500,000 shares of Common Stock for $1.00 per share and the
Company appointed St. James Securities as its exclusive agent to sell on a best
efforts basis an additional 1,000,000 shares of Common Stock in a private
placement in Canada. Under the agreement, St. James Securities was entitled to a
7% commission on all securities sold pursuant to the agreement and, three-year
warrants to purchase 200,000 shares of Common Stock for $.50 per share. In
September 1998, pursuant to the agreement, the Company sold to St. James
Securities 200,000 shares of Common Stock for $1.00 per share. The issuance of
these securities was exempt from registration under the Securities Act of 1933,
as amended, pursuant to Section 4(2) of the Securities Act, as a transaction not
involving a public offering, and pursuant to Regulation S as an off-shore
transaction with an investor which is not a U.S. Person.
In September 1998, the Company issued to Gary Weinhouse, the former Director
of Operations for the Company, 10,000 shares of Common Stock for services
rendered to the Company valued at $15,000. The issuance of these securities
was exempt from registration pursuant to Section 4(2) of the Securities Act of
1933, as amended, as a transaction not involving any public offering.
Item 3. Defaults Upon Senior Securities
N/A
Item 4. Submission of Matters to a Vote of Security Holders
N/A
Item 5. Other Information
N/A
Item 6. Exhibits and Reports on Form 8-K.
(a) Exhibits:
Exhibit 10.1 Form of 10% Convertible Note due August 13, 2000
Exhibit 27.1 Financial Data Schedule
(b) Reports on Form 8-K.
None.
<PAGE> 9
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities
Exchange Act of 1934, as amended, the Registrant caused this report to be
signed on its behalf by the undersigned, thereunto duly authorized.
MYO DIAGNOSTICS, INC.
Date: February 11, 2000 By: /s/ GERALD D. APPEL
--------------------------------------------
Gerald D. Appel, President, Chief Executive
Officer and Chairman of the Board
[Principal Financial and
Accounting Officer]
<PAGE> 1
THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933.
THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE
OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THE SECURITIES UNDER SAID ACT OR
AN OPINION OF COUNSEL (WHO MAY BE COUNSEL TO THE COMPANY) THAT SUCH
REGISTRATIONS IS NOT REQUIRED.
MYO DIAGNOSTICS, INC.
10% CONVERTIBLE NOTE DUE AUGUST 13, 2000
$40,000.00 Dated as of July 31, 1998
FOR VALUE RECEIVED, the undersigned, MYO DIAGNOSTICS, INC., a corporation duly
organized and existing under the laws of the State of California (the principal
amount of Forty Thousand and no/100 Dollars ($40,000.00) on August 13, 2000, and
to pay interest on the unpaid principal amount hereof at the rate of ten percent
(10%) per annum from the date hereof until paid. Interest shall be payable
semi-annually on June 30 and December 31 of each year, commencing December 31,
1998. Both principal and interest thereon are payable in lawful money of the
United States of American at the principal office of the Company. This note is
one of a series of notes of the Company, dated various dates, of the same title
and due dated in the aggregate principal amount of $167,000.00 (the "Notes").
ARTICLE ONE
PREPAYMENT
Section 1.01 Optional Prepayment. This Note may be prepaid by the Company in
whole or in part at any time without premium or penalty. Any such prepayment
shall be accompanied by interest to the date of prepayment.
Section 1.02 Notice of Prepayment. The Company shall give the Holder of this
Note written notice of each prepayment hereof not less than 30 days prior to the
prepayment date, specify such prepayment date, the principal amount to be
prepaid, and the date the right to convert this Note or any portion hereof shall
terminate pursuant to Section 2.01 hereof. Upon the giving of any such notice
of prepayment, the principal amount of this Note specified in such notice,
together with interest thereon, shall, subject to Section 2.01 hereof, become
due and payable on the prepayment date.
Section 1.03 Allocation of Prepayments. In the event of the prepayment of less
than all of the outstanding Notes pursuant to Section 1.01 hereof, the Company
shall allocate the principal amount so to be prepaid among the holders of Notes
in proportion to the respective principal amount of such Notes not theretofore
prepaid or converted, of which they shall be holders.
ARTICLE TWO
CONVERSION
Section 2.01 Conversion Right. The older of this Note shall have the right, at
the Holder's option, at any time and from time to time while this Note is
outstanding, or pursuant to Section 1.02 hereof (in respect of this Note or such
portion thereof) until the close of business on the first business day next
preceding the dated fixed for prepayment (unless the Company shall default in
such prepayment) to convert all or any part of the principal amount of this Note
into fully paid and non-assessable shares of Common Stock of the Company (the
"Common Stock") at the "Initial Conversion Price" (as hereinafter defined),
subject to adjustment as provided below (such price or such price, as last
adjusted, as the case may be, being referred to herein as the "Conversion
Price"). Such conversion shall be made by the surrender of this Note to the
Company at its principal office accompanied by the Holder's written request for
conversion, specifying the principal amount hereof to be converted. As used in
this Section 2.01, the following terms shall have the meanings indicated:
"Additional Offering" shall mean the sale by the Company after August 13, 1998,
of Common Stock or Convertible Debt Securities.
"Additional Offering Price" shall mean, (a) in the case of an Additional
Offering consisting of Common Stock, the total amount received by the Company in
connection with such Additional Offering, or (b) in the case of an Additional
Offering consisting of Convertible Debt Securities, the total amount received by
the Company as the consideration of the issuance of such Convertible Debt
Securities plus the minimum aggregate amount of additional consideration (as set
forth in the instruments relating thereto, without regard for any provision
contained therein for a subsequent adjustment of such consideration), payable to
the Company upon the conversion of such Convertible Debt Securities divided by
the aggregate number of shares of Common Stock issuable upon conversion of such
Convertible Debt Securities (as set forth in the instruments relating thereto,
without regard for any provision contained therein for a subsequent adjustment
of such number of shares).
<PAGE> 2
Convertible Debt Securities means promissory notes or similar instruments
issued by the Company which are convertible into Common Stock.
<PAGE> 3
Initial Conversion Price shall mean US $0.10 (ten cents) per share, provided,
however, that (i) in the event that the Company completes an Additional Offering
on or before September 13, 1998, for aggregate proceeds to the Company of US
$200,000.00 or more (not including in the case of an Additional Offering of
Convertible Debt Securities any additional consideration (as set forth in the
instruments relating thereto) payable to the Company upon the conversion of such
Convertible Debt Securities) at an Additional Offering Price equal to or in
excess of US $0.10 (ten cents) per share, "Initial Conversion Price" shall mean
the "Additional Offering Price", (ii) in the event that the Company completes
and Additional Offering on or before September 13, 1998, for aggregate proceeds
to the Company of US $200,000.00 or more (not including in the case of an
Additional Offering of Convertible Debt Securities any additional consideration
(as set forth in the instruments relating thereto) payable to the Company upon
the conversion of such Convertible Debt Securities) at an Additional Offering
Price of less than US $0.10 (ten cents) per share, "Initial Conversion Price"
shall mean the "Additional Offering Price", and no adjustment to the Conversion
Price shall be made under the provisions of Section 2.04 hereof with respect to
such Additional Offering, and (iii) in the event that the Company completes an
Additional Offering on or before September 13, 1998, for aggregate proceeds to
the Company of less than US $200,000.00 (not including in the case of an
Additional Offering of Convertible Debt Securities any additional consideration
(as set forth in the instruments relating thereto) payable to the Company upon
the conversion of such Convertible Debt Securities) "Initial Conversion Price"
shall mean the lesser of the Additional Offering Price and US $0.10 (ten cents)
per share, and no adjustment to the Conversion Price shall be made under the
provisions of Section 2.4 hereof with respect to such Additional Offering.
Section 2.02 Issuance of Certificates; Partial Conversion. Promptly after
receipt of the written request referred to in Section 2.01 hereof and surrender
of this Note as aforesaid, the Company shall issue and deliver to the Holder,
registered in such Holder's name (or in such other name or names as shall be
specified in such written request), a certificate or certificates for the number
of full shares of Common Stock issuable upon conversion of this Note (or
specified portion hereof), which certificates shall bear a legend to the same
effect as the legend set forth at the beginning of this Note. Such conversion
shall be deemed to have been effected and the Conversion Price shall be
determined as of the close of business on the date on which such written request
shall have been received by the Company, and this Note shall have been
surrendered as aforesaid, and the rights of the Holder hereof (or specified
portion thereof) shall cease and the person or persons in whose name such
certificate or certificates are to be registered shall be deemed to have become
a holder of record of the shares of Common Stock issuable upon such conversion.
Upon conversion of only a portion of this Note, the Company shall issue and
deliver to the Holder, at the expense of the Company, a new Note in the form
hereof for the unconverted portion hereof and bearing interest from the date to
which interest has been paid on such unconverted portion.
Section 2.03 Fraction Shares; Accrued Interest. No fractional share of Common
Stock shall be issued upon conversion of this Note or any portion hereof,
<PAGE> 4
and no payment or adjustment shall be made upon any such conversion with
respect to the Common Stock issued upon such conversion. If any fractional
interest in a share of Common Stock would, except for the provisions hereof, be
issuable upon the conversion of this note or any portion hereof, the Company
shall pay to the Holder an amount in cash equal to the current market price (as
determined by the Company in good faith) of such fractional interest. The
company shall pay all interest on this Note or specified portion hereof
surrendered for conversion accrued to the date upon which the aforementioned
written request shall have been received by the Company.
Section 2.04 Adjustment of Conversion Price. The Conversion Price shall be
subject to adjustment from time to time as follows:
(a) Definitions. As used in this Section 2.04, the following terms shall have
the meanings indicated:
"Options" shall mean rights, options or warrants to purchase either Common
Stock or Convertible Securities.
"Initial Date" shall mean August 13, 1998.
"Convertible Securities" shall mean any evidences of indebtedness, shares (other
than Common Stock) or other securities convertible into Common Stock.
"Other Securities" shall mean any securities of the company other than Common
Stock and any other securities which the holder of a Note at any time shall be
entitled to receive, or shall have received, upon conversion of Note, in lieu of
or in addition to Common Stock, or which at any time shall be issuable or shall
have been issued in exchange for, or as a distribution with respect to, Common
Stock (or other Securities).
(b) No Adjustment of Conversion Price. No adjustment in the Conversion Price
shall be made in respect of the issuance of Additional Shares of Common Stock
unless the consideration per share for an Additional Share of common Stock
issued or deemed to be issued by the Company is less than the per share
Conversion Price in effect on the date of such issue.
(c) Deemed Issue of Additional Shares of Common Stock.
(i) Options and Convertible Securities. In the event the Company, on or after
the Initial Date, shall issue any Options or Convertible Securities, then the
maximum number of shares (as set forth in the instrument relating thereto
without regard to any provisions contained therein for a subsequent adjustment
of such number) of Common Stock issuable upon the exercise of such Options, or
in the case of Convertible Securities and Options therefore, the shares into
which such Convertible Securities may be converted, shall be deemed to be
Additional Share of Common Stock issued as of the time of such issue, proved
that Additional Shares of Common Stock shall not be deemed to have been issued
unless the consideration per share (determined pursuant to Section 2.04 (e)
hereof, of such Additional Shares of Common Stock would be less than the
Conversion Price in effect on the date of and immediately prior to such issue,
and provided further that in any such case in which Additional Shares of Common
Stock are deemed to be issued:
(a) no further adjustment in the Conversion Price shall be made upon the
subsequent issue of Convertible Securities or shares of Common Stock, upon the
exercise of such Options or the conversion of such Convertible Securities:
(b) if such Options or Convertible Securities by their terms provide, with the
passage of time or otherwise, for any decrease in the consideration payable to
the Company, or increase in the number of share of Common Stock issuable, upon
the exercise, conversion or exchange thereof, the Conversion Price computed upon
the original issue thereof, and any subsequent adjustment based thereon, shall,
upon any such increase or decrease becoming effective, be recomputed to reflect
such increase or decrease insofar as it affects such options or the rights of
conversion or exchange under such Convertible Securities;
(c) Upon the expiration of any such Options or any rights of conversion under
such Convertible Securities which shall not have been exercised, the Conversion
Price computed upon the original issue thereof, and any subsequent adjustments
based thereon, shall, upon such expiration, be recomputed as if:
(x) in the case of Options for Convertible Securities or Options for Common
Stock the only Additional Share of Common Stock issued were the shares of Common
Stock actually issued upon the exercise of such Options or the conversion of
Convertible Securities and the consideration received therefor was the
consideration actually received by the Company for the issue of such Convertible
Securities which were actually converted, and
<PAGE> 5
(y) in the case of Options for Convertible Securities only the Convertible
Securities actually issued upon the exercise thereof were issued at the time of
issue of such Options, and the consideration received by the Company for the
Additional Shares of Common Stock deemed to have been issued was the
consideration actually received by the Company for the issue of all such
options, whether or not exercised, plus the consideration deemed to have been
received by the Company (determined pursuant to Section 2.04 (e)) upon the issue
of the Convertible Securities with respect to which such Options were actually
exercised;
(d) no readjustments pursuant to Section 2.04 (c)(I)(b) or Section 2.04
(c)(I)(c) above shall have the effect of increasing the Conversion Price by an
amount in excess of the amount of the adjustment thereof originally made in
respect of the issue of such Options or Convertible Securities; and
(e) in the case of any Options which expire by their terms not more than 30 days
after the date of issue thereof, no adjustment of the Conversion Price shall be
made until the expiration or exercise of all such Options, whereupon such
adjustment shall be made in the same manner provided in Section 2.04 (c)(I)(c)
above.
(i) Stock Dividends and Subdivisions. In the event the Company at any time or
from time to time on or after the Initial Date shall pay any dividend on Common
Stock payable in common Stock, or effect a subdivision of the outstanding shares
of Common Stock into greater number of shares, Additional Share of Common Stock
shall be deemed to have been issued:
(a) in the case of any such dividend, immediately after the close of business on
the record date for the determination of holders of any class of securities
entitled to receive such dividend, or
(b) in the case of any such subdivision, at the close of business on the date
immediately prior to the date upon which such corporate action becomes
effective.
(d) Adjustment of Conversion Price Upon Issuance of Additional Shares of Common
Stock. Except as otherwise provided in Section 2.04 (g), in the event the
Company shall issue Additional Shares of Common Stock (including Additional
Shares of Common Stock deemed to be issued pursuant to Section 2.04(c)) without
consideration or for a consideration per share less than the Conversion Price
shall be reduced, concurrently with such issue, to a price (calculated to the
nearest cent) determined by multiplying such Conversion Price by a fraction, the
numerator of which shall be the consideration per share received by the Company
for Additional Shares of Common Stock issued pursuant to Section 2.03(c)(I) and
the denominator of which shall be the Conversion Price in effect on the date of,
and immediately prior to the issuance of Additional Shares of Common Stock.
(e) Determination of Consideration. For purposes of this Section 2.04, the
consideration received by the Company for the issue of any Addition Shares of
Common Stock shall not included interest accrued and unpaid on Convertible
Securities. The consideration per share received by the Company for Additional
Shares of Common Stock deemed to have been issued pursuant to Section 2.04
(c)(I), relating to Option and Convertible Securities, shall be determined by
dividing:
(i) the total amount, if any, received or receivable by the Company as
consideration for the issue of such Options or Convertible Securities, plus the
minimum aggregate amount of additional consideration (as set forth in the
instruments relating thereto, without regard to any provision contained herein
for a subsequent adjustment of such consideration) payable to the Company upon
the exercise of such Options or the conversion of such Convertible Securities
and the conversion of such Convertible Securities, by
(ii) the maximum number of share of Common Stock (as set forth in the
instruments relating thereto, without regard to any provision contained therein
for a subsequent adjustment of such number) issuable upon the exercise of such
Options or the conversions or the conversion or exchange of such Convertible
Securities.
(f) Adjustment of Conversion Price Upon Issuance of Other Securities. In the
event Other securities shall be issued or shall become subject to issue upon the
conversion of any Notes (or Other Securities) of the Company (or any issuer of
Other Securities) for a consideration such as to dilute the conversion rights of
the holders of the Notes, the computations and adjustments with respect to the
Conversion Price shall be made nearly as possible in the manner so provided and
applied to determine the number of Other Securities from time to time receivable
upon the conversion hereof.
(g) Adjustment for Combinations, Reclassifications, Consolidation of Common
<PAGE> 6
Stock, Stock Dividends or Stock Subdivisions. In the event (a) the outstanding
shares of Common Stock shall be combined, reclassified or consolidated into a
lesser number of shares of Common Stock, or (b) any Additional Shares of Common
Stock shall be deemed to have been issued pursuant to Section 2.04 (c)(ii)
relating to stock dividends and stock subdivisions, the Conversion Price in
effect immediately prior to such combination, reclassification, consolidation,
stock dividend, or stock subdivision shall, concurrently with the effectiveness
of such stock combination, reclassification, consolidation, stock dividend, or
stock subdivision be proportionately increased or decreased.
(h) Adjustment for Merger of Reorganization, etc. In case of any consolidations
merger of the Company with or into another corporation or the conveyance of
substantially all of the assets of the company to another corporation, each Note
shall thereafter be convertible into the number of shares of stock, or other
securities, or other property, to which a holder of the number of shares of
Common Stock of the Company deliverable upon conversion of this Note would have
been entitled upon such consolidation, merger or conveyance, and appropriate
adjustment (as determined in good faith by the Board of Directors) shall be made
in the application of the provisions herein set forth with respect to the rights
of the Holder hereof, to the end that the provisions set forth herein (including
provisions with respect to changes in an other adjustments of the Conversion
Price) shall thereafter be applicable, as nearly as reasonably may be, in
relation to any shares of stock, or other securities, or other property
thereafter deliverable upon conversion.
Section 2.05 Notice of Adjustment. Upon any adjustment of the Conversion
Price, the Company shall give written notice thereof to the Holder thereof,
which notice shall state the Conversion Price resulting from such adjustment and
set forth in reasonable detail the method of calculation and the facts upon
which such calculation is based.
Section 2.06 Other Notices. In the event the Company proposes to take any
action of the type requiring an adjustment of the Conversion Price, the Company
shall give written notice thereof to the Holder of this Note, which notice shall
specify the record date, if any, with respect to any such action and the date on
which such action is to take place. Such notice shall also set forth such facts
with respect thereto as shall be reasonable necessary to indicate the effect of
such action (to the extent such effect may be known at the date of such notice)
on the Conversion Price and the number, kind or class of shares or other
securities or property which shall be deliverable or purchasable upon the
occurrence of such action or deliverable upon conversion of the Notes. In case
of any action which would require the fixing of a record date, such notice shall
be given at least 20 days prior to the date so fixed, and in the case of all
other action, such notice shall be given at least 30 days prior to the taking of
such proposed action. In addition, whenever the Company proposes to declare a
dividend or distribution with respect to the Common Stock, it will give the
Holder of this Note written notice thereof at least 20 days prior to the record
date for such dividend or distribution.
Section 2.07 Reservation of Shares. The Company will at all times reserve and
keep available, free from preemptive rights, out of its authorized but unissued
shares of Common Stock, solely for the purpose of issue upon the conversion of
Notes, sufficient shares to provide for the conversion of all outstanding Notes.
The Company covenants that all shares of Common Stock which may be issued upon
conversion of this Note will, upon issuance by the Company in accordance with
the terms of this Note, be duly authorized, validly issued, fully paid and
non-assessable and free from any claims, liens or encumbrances with respect to
the issuance thereof, except for any restrictions on transfer imposed by
applicable securities laws. The Company will take all such action as may be
necessary to assure that all such shares of Common Stock may be so issued
without violation of any applicable law or regulation, or any requirement of any
national stock exchange upon which the Common Stock may be listed.
Section 2.08 Government Approvals. If any shares of Common Stock required to
be reserved for the purpose of conversion of this Note require registration with
or approval of any governmental authority under an applicable law, or listing on
any national securities exchange, before such shares may be issued upon
conversion, the Company will, at its expense and as expeditiously as possible,
cause such shares to be duly registered or approved or listed on the relevant
national securities exchange, as the case may be.
Section 2.09 Taxes The Company will pay all documentary, stamp or other
transactional taxes attributable to the issuance or delivery of shares of Common
Stock upon conversion of this Note, provided, however, that the Company shall
not be required to pay any taxes which may be payable in respect of any transfer
involved in the issuance or delivery of any certificate for such shares in a
name other than that of the Holder of this Note.
ARTICLE FOUR
COVENANTS
<PAGE> 7
Section 4.01 Use of Proceeds. The Company covenants that the proceeds from
the issuance of the Notes have or will be used to pay current operating expenses
of the Company, including payroll, payroll taxes, rent, compensation of William
L. Wayne or any other consultant approved by the holders of a majority in
principal amount of the Notes, and any other current operating expense approved
by William L. Wayne.
Section 4.02 Indebtedness. The Company covenants and agrees that during the
period commencing on August 13, 1998 and ending on August 13, 1999, it will not,
so long as any principal of, or interest on, the Notes remains outstanding and
unpaid, incur any indebtedness, whether secured or unsecured, for borrowed
money, including, without limitation, any Additional Offering of Convertible
Debt Securities (as such terms are defined in Section 2.01 hereof) without the
prior written consent of the holds of at lease 50% of the principal amount of
the Notes then outstanding.
ARTICLE FIVE
EVENTS OF DEFAULT
Section 5.01 Definitions of Effect. If any of the following events
("Events of Default") shall occur and be continuing:
(a) Default shall be made in the payment of the principal of this or any other
Note when and as the same shall become due and payable, whether at maturity or
at a date fixed for prepayment or by acceleration or otherwise; or
(b) Default shall be made in the payment of any installment of interest upon
this or any other Note when the same shall become due and payable, and such
default shall continue for a period of 5 days; or
(c) Default shall be made in the due observance or performance of any other
covenant, condition or agreement on the part of the Company to be observed or
performed pursuant to the terms hereof and such default shall continue for 30
days; or
(d) Default shall be made in any payment of principal of, or interest on, any
other indebtedness of the Company and such default shall continue for more than
the period of grace, if any, provided with respect hereto;
(e) (I) the Company shall commence any case, proceeding or other action (A)
under any existing or future law of any jurisdiction, domestic or foreign,
relating to bankruptcy, insolvency, reorganization or relief of debtors, seeking
to have an order for relief entered with respect to it, or seeking to
adjustment, winding-up, liquidation, dissolution, composition or other relief
with respect to it or its debt, or (B) seeking appointment of a receiver,
trustee, custodian or other similar official for it or for all or any
substantial part of its assets, or the Company shall make a general assignment
for the benefit of its creditors; or (ii) there shall be commenced against the
Company any case, proceeding or other action of a nature referred to in clause
(I) above which (A) result in the entry of any order for relief or any such
adjudication or appointment or (B) remains un-dismissed, un-discharged, or un-
bonded for a period of 60 days; or (iii) there shall be commenced against the
Company any case, proceeding or other action seeking issuance of a warrant of
attachment, execution, restraint or similar process against all or any
substantial part of its assets which result in the entry of an order for any
such relief which shall not have been vacated, discharges, or stayed or bonded
pending appeal within 60 days from the entry thereof; or (iv) the Company shall
take any action in furtherance of, or indicating its consent to, approval of, or
acquiescence in, any of the acts set forth in clauses (I), (ii) or (iii) above;
or (v) the Company shall generally not, or shall be unable to, or shall admit in
writing an inability to, pay its debts as they become due; then, and in each and
every such case, the Holder of this Note may, by written notice to the Company
declare all sums of principal and interest then remaining unpaid on this Note
and all other amount payable hereunder, to be immediately due and payable,
whereupon the same shall immediately become due and payable. Except as
expressly provided above in this Section, presentment, demand, protest and all
other notices of any kind are hereby expressly waived.
ARTICLE SIX
MISCELLANEOUS
Section 6.01 Amendments. This Note may only be amended in writing signed by
the Holder and the Company.
Section 6.02 Notices. Any notice or other communication to the Holder of this
Note required or permitted hereunder shall be in writing and shall be personally
delivered or mailed, postage paid, by registered or certified mail, if the
Holder, addressed to such Holder at c/o Tullet & Tokyo Forex Ltd., 154
University Avenue, Suite 400, Toronto, Ontario M5H 3Y9, Canada or such other
<PAGE> 8
address as such Holder may designate to the Company in writing, and if to the
Company, addressee to the Company at 3760 South Robertson Blvd., Culver City, CA
90232 or to such other address as the Company may in writing designate to the
Holder.
Section 6.03 Suits for Enforcement. In case any one or more Events of Default
shall occur and be continuing, the Holder of this Note may precede to protect
and enforce its rights by suits in equity, action at law and/or by other
appropriate proceeding, whether for the specific performance (to the extent
permitted by law) of any covenant or agreement contained in this note or in aid
of the exercise of any power granted in this Note, or may proceed to enforce any
other legal or equitable right of the Holder of this Note. If any holder of a
Note shall demand payment thereof or take any action in respect of an Event of
Default, the Company will forthwith give written notice to the other holders of
Notes, specifying such action and the nature of the Event of Default.
Section 6.04 Remedies Cumulative. No remedy herein conferred upon the Holder
of this Note is intended to be exclusive of any other remedy, and each and every
such remedy shall be cumulative and shall be in addition to every other remedy
given hereunder or now or hereafter existing at law or in equity or by statute
or otherwise.
Section 6.05 Remedies no Waived. No course of dealing between the Company and
the Holder hereof shall operate as a waiver of any right of any Holder hereof
and no delay of the part of the Holder hereof in exercising any right hereunder
shall so operate.
Section 6.06 Successors and Assigns. All of the covenants and agreements in
the Note contained by or on behalf of the Company shall bind its successors and
assigns, whether so expressed or not.
Section 6.07 Headings. The headings of the section sand subsections of this
Note are inserted for convenience only and shall not be deemed to constitute a
part of this Note.
Section 6.08 Governing Law. This Note shall be deemed to be a contract made
under the laws of the State of California and shall be construed in accordance
with such laws.
IN WITNESS WHEREOF, the undersigned, has caused this Note to be executed in
its name and on its behalf as of the day and year first above written.
MYO DIAGNOSTICS, INC.
By:
Gerald D. Appel
President
<PAGE> 9
August 26, 1998
Myo Diagnostics Inc.
3760 S. Robertson Boulevard
Culver City, CA 90232
Attention: Gerald Appel, President & Chief Executive Officer
Dear Mr. Appel:
Re: Proposed Financing
St. James Securities Inc. ("SJS") hereby agrees to act as exclusive agent for
Myo Diagnostics Inc. (the "Corporation") in connection with a proposed offering
of equity units ("Equity Units") to be created and issued by the Corporation
pursuant to the following terms and conditions (the "Offering").
Issuer: Myo Diagnostics Inc.
Size of Offering:Up to 1.5 million Equity Units
Purchased Securities: Subject to adjustment and potential restrictions in
certain events, each Equity Unit shall be exercisable, for no additional
consideration, to acquire common shares ("Common Share") of the Corporation.
Agent: St. James Securities Inc.
Price:Such price as SJS and the Corporation may agree (the "Price"),
however such price will not be less than $US1.00 per Common Share.
Closing Date: February 26, 1999 or such other date as SJS and the
Corporation may agree (the "Closing Date").
Description of Agency: SJS agrees to purchase as principle investor no less
than 500,000 Equity Units prior to September 11, 1998. SJS will also act, on a
"best efforts" private placement basis, as exclusive agent for an additional 1
million Equity Units. SJS is not obliged under any circumstances to purchase in
excess of 500,000 Equity Units but may choose to do so in its sole discretion.
Due Diligence: Prior to the filing of the (final) prospectus qualifying the
Common Shares issuable on exercise of the Equity Units, the Corporation shall
allow SJS and their representatives to conduct all due diligence investigations
which SJS may reasonably require to fulfill their obligations as underwriters
and to responsibly execute the certificate required of them in the preliminary
prospectus and the (final) prospectus.
<PAGE> 10
SJS's Fees: 7% of gross proceeds of the Offering (the "Commission"),
Compensation Option: SJS shall also receive two hundred thousand (200,000)
compensation options, each compensation option entitling SJS to purchase one
Common Share of the Corporation at a price of $0.50 per common share at any time
prior to August 26, 2001.
Costs and Expenses: Offering costs and expenses are to be borne by the
Corporation, including the costs of SJS, its Consultant and its designated legal
counsel, all payable on the Closing Date.
If the foregoing accurately reflects your understanding of the terms of the
Offering, please execute this letter where indicated below and return a copy
(personally, by facsimile, by post or by courier) to St. James Securities Inc.,
150 York Street, Suite 1814, Toronto, Ontario, M5H 3S5, Attention: Rodger Gray,
President, prior to 9:30 a.m. September 2, 1998, whereupon this letter shall
become a binding agreement
between us.
Yours very truly,
ST. JAMES SECURITIES INC.
Per: _________________________________
John Illidge
Chairman
The foregoing accurately reflects the terms of the transaction that we are to
enter into and such terms are hereby agreed to.
ACCEPTED this day of August, 1998.
MYO DIAGNOSTICS INC.
Per: _________________________________
Gerald Appel
President and Chief Executive
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM UNAUDITED
FINANCIAL STATEMENTS OF MYO DIAGNOSTICS, INC. DATED JUNE 30, 1998 AND IS
QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1998
<PERIOD-START> JAN-01-1998
<PERIOD-END> SEP-30-1998
<CASH> 0
<SECURITIES> 0
<RECEIVABLES> 0
<ALLOWANCES> 0
<INVENTORY> 0
<CURRENT-ASSETS> 6,039
<PP&E> 6,039
<DEPRECIATION> 47,136
<TOTAL-ASSETS> 193,220
<CURRENT-LIABILITIES> 754,868
<BONDS> 0
0
0
<COMMON> 5,769,956
<OTHER-SE> (862,400)
<TOTAL-LIABILITY-AND-EQUITY> (6,777,356)
<SALES> 0
<TOTAL-REVENUES> 0
<CGS> 0
<TOTAL-COSTS> 1,052,665
<OTHER-EXPENSES> 0
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 23,719
<INCOME-PRETAX> (1,077,425)
<INCOME-TAX> 0
<INCOME-CONTINUING> 0
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,077,425)
<EPS-BASIC> (0.13)
<EPS-DILUTED> (0.13)
</TABLE>
